mrsa strains Search Results


s aureus mrsa strain f  (ATCC)
98
ATCC s aureus mrsa strain f
S Aureus Mrsa Strain F, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrsa+strains/Staphylococcus+aureus/10__1007_slash_s11814___025___00583___1-37-1-10
Average 98 stars, based on 1 article reviews
s aureus mrsa strain f - by Bioz Stars, 2026-10
98/100 stars
  Buy from Supplier
mrsa bacterial strain  (Hospitex Diagnostics)
90
Hospitex Diagnostics mrsa bacterial strain
Mrsa Bacterial Strain, supplied by Hospitex Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrsa+strains/mrsa+bacterial+strain/10__36348_slash_sjbr__2023__v08i12__001-38-21-37
Average 90 stars, based on 1 article reviews
mrsa bacterial strain - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
genomic dna from mrsa strain hfh- 30106 (nr- 10320)  (BEI Resources)
90
BEI Resources genomic dna from mrsa strain hfh- 30106 (nr- 10320)
Genomic Dna From Mrsa Strain Hfh 30106 (Nr 10320), supplied by BEI Resources, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrsa+strains/methicillin+resistant+staphylococcus+aureus++mrsa++strain+hfh+30106/pm40063799-86-0-12
Average 90 stars, based on 1 article reviews
genomic dna from mrsa strain hfh- 30106 (nr- 10320) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
mrsa strains  (Federation of European Neuroscience Societies)
90
Federation of European Neuroscience Societies mrsa strains
Mrsa Strains, supplied by Federation of European Neuroscience Societies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrsa+strains/mrsa+strains/10__1111_slash_j__1574___695x__2005__00009__x-249-25-10
Average 90 stars, based on 1 article reviews
mrsa strains - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
methicillin-resistant staphylococcus aureus atcc43300  (China Center for Type Culture Collection)
90
China Center for Type Culture Collection methicillin-resistant staphylococcus aureus atcc43300
Methicillin Resistant Staphylococcus Aureus Atcc43300, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrsa+strains/mrsa+strain+atcc43300/pm35752262-77-24-53
Average 90 stars, based on 1 article reviews
methicillin-resistant staphylococcus aureus atcc43300 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
dns mrsa strains  (Cubist Pharmaceuticals)
90
Cubist Pharmaceuticals dns mrsa strains
High-inoculum (109 CFU/mL) modified checkerboard MIC assays of daptomycin-nonsusceptible <t>MRSA</t> isolates (A) C4 and (B) C37 against (A1 and B1) daptomycin plus Intesti13 + Sb-1, (A2 and B2) ceftaroline plus Intesti13 + Sb-1, and (A3 and B3) daptomycin plus ceftaroline plus Intesti13 + Sb-1. Phage was added to each non-growth control (GC) and non-media control (MC) well in A3 and B3 at a phage MOI of 0.1. Values were normalized to the MC and converted to percent growth versus the untreated GC. MOI, multiplicity of infection; DAP, daptomycin; CPT, ceftaroline. CB squares within the orange outline represent synergistic bacterial killing (fractional inhibitory concentration ≤0.5).
Dns Mrsa Strains, supplied by Cubist Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrsa+strains/dns+mrsa+strains/pmc10989002-284-1-21
Average 90 stars, based on 1 article reviews
dns mrsa strains - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
mrsa strain who-2  (Rongxin Bio Tech Co Ltd)
90
Rongxin Bio Tech Co Ltd mrsa strain who-2
High-inoculum (109 CFU/mL) modified checkerboard MIC assays of daptomycin-nonsusceptible <t>MRSA</t> isolates (A) C4 and (B) C37 against (A1 and B1) daptomycin plus Intesti13 + Sb-1, (A2 and B2) ceftaroline plus Intesti13 + Sb-1, and (A3 and B3) daptomycin plus ceftaroline plus Intesti13 + Sb-1. Phage was added to each non-growth control (GC) and non-media control (MC) well in A3 and B3 at a phage MOI of 0.1. Values were normalized to the MC and converted to percent growth versus the untreated GC. MOI, multiplicity of infection; DAP, daptomycin; CPT, ceftaroline. CB squares within the orange outline represent synergistic bacterial killing (fractional inhibitory concentration ≤0.5).
Mrsa Strain Who 2, supplied by Rongxin Bio Tech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrsa+strains/mrsa+strain+who+2/pmc06278838-32-1-9
Average 90 stars, based on 1 article reviews
mrsa strain who-2 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
mrsa clinical strain  (Clinical and Laboratory Standards Institute)
90
Clinical and Laboratory Standards Institute mrsa clinical strain
High-inoculum (109 CFU/mL) modified checkerboard MIC assays of daptomycin-nonsusceptible <t>MRSA</t> isolates (A) C4 and (B) C37 against (A1 and B1) daptomycin plus Intesti13 + Sb-1, (A2 and B2) ceftaroline plus Intesti13 + Sb-1, and (A3 and B3) daptomycin plus ceftaroline plus Intesti13 + Sb-1. Phage was added to each non-growth control (GC) and non-media control (MC) well in A3 and B3 at a phage MOI of 0.1. Values were normalized to the MC and converted to percent growth versus the untreated GC. MOI, multiplicity of infection; DAP, daptomycin; CPT, ceftaroline. CB squares within the orange outline represent synergistic bacterial killing (fractional inhibitory concentration ≤0.5).
Mrsa Clinical Strain, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrsa+strains/mrsa+clinical+strain/pmc08639810__mmc1-27-17-28
Average 90 stars, based on 1 article reviews
mrsa clinical strain - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
community-associated mrsa isolate strain 6-8548a  (JMI Laboratories)
90
JMI Laboratories community-associated mrsa isolate strain 6-8548a
High-inoculum (109 CFU/mL) modified checkerboard MIC assays of daptomycin-nonsusceptible <t>MRSA</t> isolates (A) C4 and (B) C37 against (A1 and B1) daptomycin plus Intesti13 + Sb-1, (A2 and B2) ceftaroline plus Intesti13 + Sb-1, and (A3 and B3) daptomycin plus ceftaroline plus Intesti13 + Sb-1. Phage was added to each non-growth control (GC) and non-media control (MC) well in A3 and B3 at a phage MOI of 0.1. Values were normalized to the MC and converted to percent growth versus the untreated GC. MOI, multiplicity of infection; DAP, daptomycin; CPT, ceftaroline. CB squares within the orange outline represent synergistic bacterial killing (fractional inhibitory concentration ≤0.5).
Community Associated Mrsa Isolate Strain 6 8548a, supplied by JMI Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrsa+strains/community+associated+mrsa+isolate+strain+6+8548a/10__1128_slash_aac__01565___10-38-4-12
Average 90 stars, based on 1 article reviews
community-associated mrsa isolate strain 6-8548a - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
animal mrsa strain 19  (GeneOhm Sciences Inc)
90
GeneOhm Sciences Inc animal mrsa strain 19
High-inoculum (109 CFU/mL) modified checkerboard MIC assays of daptomycin-nonsusceptible <t>MRSA</t> isolates (A) C4 and (B) C37 against (A1 and B1) daptomycin plus Intesti13 + Sb-1, (A2 and B2) ceftaroline plus Intesti13 + Sb-1, and (A3 and B3) daptomycin plus ceftaroline plus Intesti13 + Sb-1. Phage was added to each non-growth control (GC) and non-media control (MC) well in A3 and B3 at a phage MOI of 0.1. Values were normalized to the MC and converted to percent growth versus the untreated GC. MOI, multiplicity of infection; DAP, daptomycin; CPT, ceftaroline. CB squares within the orange outline represent synergistic bacterial killing (fractional inhibitory concentration ≤0.5).
Animal Mrsa Strain 19, supplied by GeneOhm Sciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrsa+strains/animal+mrsa+strain+19/pmc03008470-34-19-22
Average 90 stars, based on 1 article reviews
animal mrsa strain 19 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
mrsa strain ksa8  (Federation of European Neuroscience Societies)
90
Federation of European Neuroscience Societies mrsa strain ksa8
High-inoculum (109 CFU/mL) modified checkerboard MIC assays of daptomycin-nonsusceptible <t>MRSA</t> isolates (A) C4 and (B) C37 against (A1 and B1) daptomycin plus Intesti13 + Sb-1, (A2 and B2) ceftaroline plus Intesti13 + Sb-1, and (A3 and B3) daptomycin plus ceftaroline plus Intesti13 + Sb-1. Phage was added to each non-growth control (GC) and non-media control (MC) well in A3 and B3 at a phage MOI of 0.1. Values were normalized to the MC and converted to percent growth versus the untreated GC. MOI, multiplicity of infection; DAP, daptomycin; CPT, ceftaroline. CB squares within the orange outline represent synergistic bacterial killing (fractional inhibitory concentration ≤0.5).
Mrsa Strain Ksa8, supplied by Federation of European Neuroscience Societies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrsa+strains/mrsa+strain+ksa8/pm10612735-33-0-16
Average 90 stars, based on 1 article reviews
mrsa strain ksa8 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
linezolid-resistant mrsa strain  (JMI Laboratories)
90
JMI Laboratories linezolid-resistant mrsa strain
High-inoculum (109 CFU/mL) modified checkerboard MIC assays of daptomycin-nonsusceptible <t>MRSA</t> isolates (A) C4 and (B) C37 against (A1 and B1) daptomycin plus Intesti13 + Sb-1, (A2 and B2) ceftaroline plus Intesti13 + Sb-1, and (A3 and B3) daptomycin plus ceftaroline plus Intesti13 + Sb-1. Phage was added to each non-growth control (GC) and non-media control (MC) well in A3 and B3 at a phage MOI of 0.1. Values were normalized to the MC and converted to percent growth versus the untreated GC. MOI, multiplicity of infection; DAP, daptomycin; CPT, ceftaroline. CB squares within the orange outline represent synergistic bacterial killing (fractional inhibitory concentration ≤0.5).
Linezolid Resistant Mrsa Strain, supplied by JMI Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mrsa+strains/linezolid+resistant+mrsa+strain/10__1128_slash_aac__00019___10-149-21-14
Average 90 stars, based on 1 article reviews
linezolid-resistant mrsa strain - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


High-inoculum (109 CFU/mL) modified checkerboard MIC assays of daptomycin-nonsusceptible MRSA isolates (A) C4 and (B) C37 against (A1 and B1) daptomycin plus Intesti13 + Sb-1, (A2 and B2) ceftaroline plus Intesti13 + Sb-1, and (A3 and B3) daptomycin plus ceftaroline plus Intesti13 + Sb-1. Phage was added to each non-growth control (GC) and non-media control (MC) well in A3 and B3 at a phage MOI of 0.1. Values were normalized to the MC and converted to percent growth versus the untreated GC. MOI, multiplicity of infection; DAP, daptomycin; CPT, ceftaroline. CB squares within the orange outline represent synergistic bacterial killing (fractional inhibitory concentration ≤0.5).

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model

doi: 10.1128/aac.01388-23

Figure Lengend Snippet: High-inoculum (109 CFU/mL) modified checkerboard MIC assays of daptomycin-nonsusceptible MRSA isolates (A) C4 and (B) C37 against (A1 and B1) daptomycin plus Intesti13 + Sb-1, (A2 and B2) ceftaroline plus Intesti13 + Sb-1, and (A3 and B3) daptomycin plus ceftaroline plus Intesti13 + Sb-1. Phage was added to each non-growth control (GC) and non-media control (MC) well in A3 and B3 at a phage MOI of 0.1. Values were normalized to the MC and converted to percent growth versus the untreated GC. MOI, multiplicity of infection; DAP, daptomycin; CPT, ceftaroline. CB squares within the orange outline represent synergistic bacterial killing (fractional inhibitory concentration ≤0.5).

Article Snippet: The DNS MRSA strains selected for evaluation in the studies herein were initially isolated from bacteremic patients and obtained from the Cubist Pharmaceuticals Isolate Collection ( 30 ).

Techniques: Modification, Control, Infection, Concentration Assay

Bacterial quantification in high-inoculum (109 CFU/mL) 24-h time-kill experiments of GC, DAP, CPT, or DAP + CPT (each at 0.5× MIC) combined with phage cocktail Intesti13 + Sb-1 (MOI ranging from 0.01 to 1 each) against DAP-nonsusceptible MRSA isolates (A) C4 and (B) C37. The error bars indicate standard deviation of two replicate experiments. P values were determined using one-way ANOVA and Tukey’s post hoc test. Significant differences in CFU/mL between regimens is notated with a bracket and asterisk. Abbreviations: CFU, colony-forming units; GC, growth control; DAP, daptomycin; CPT, ceftaroline; MIC, minimum inhibitory concentration; MOI, multiplicity of infection; MRSA, methicillin-resistant Staphylococcus aureus; ANOVA, analysis of variance.

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model

doi: 10.1128/aac.01388-23

Figure Lengend Snippet: Bacterial quantification in high-inoculum (109 CFU/mL) 24-h time-kill experiments of GC, DAP, CPT, or DAP + CPT (each at 0.5× MIC) combined with phage cocktail Intesti13 + Sb-1 (MOI ranging from 0.01 to 1 each) against DAP-nonsusceptible MRSA isolates (A) C4 and (B) C37. The error bars indicate standard deviation of two replicate experiments. P values were determined using one-way ANOVA and Tukey’s post hoc test. Significant differences in CFU/mL between regimens is notated with a bracket and asterisk. Abbreviations: CFU, colony-forming units; GC, growth control; DAP, daptomycin; CPT, ceftaroline; MIC, minimum inhibitory concentration; MOI, multiplicity of infection; MRSA, methicillin-resistant Staphylococcus aureus; ANOVA, analysis of variance.

Article Snippet: The DNS MRSA strains selected for evaluation in the studies herein were initially isolated from bacteremic patients and obtained from the Cubist Pharmaceuticals Isolate Collection ( 30 ).

Techniques: Standard Deviation, Control, Concentration Assay, Infection

Efficacy of phage-antibiotic combinations in 168-h ex vivo PK/PD SEV models against daptomycin-nonsusceptible MRSA strain C4. Abbreviations: CFU, colony-forming units; GC, growth control; DAP, daptomycin; CPT, ceftaroline.

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model

doi: 10.1128/aac.01388-23

Figure Lengend Snippet: Efficacy of phage-antibiotic combinations in 168-h ex vivo PK/PD SEV models against daptomycin-nonsusceptible MRSA strain C4. Abbreviations: CFU, colony-forming units; GC, growth control; DAP, daptomycin; CPT, ceftaroline.

Article Snippet: The DNS MRSA strains selected for evaluation in the studies herein were initially isolated from bacteremic patients and obtained from the Cubist Pharmaceuticals Isolate Collection ( 30 ).

Techniques: Ex Vivo, Control

Efficacy of phage-antibiotic combinations in 168-h ex vivo PK/PD SEV models against daptomycin-nonsusceptible MRSA strain C37. Abbreviations: CFU, colony-forming units; GC, growth control; DAP, daptomycin; CPT, ceftaroline.

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model

doi: 10.1128/aac.01388-23

Figure Lengend Snippet: Efficacy of phage-antibiotic combinations in 168-h ex vivo PK/PD SEV models against daptomycin-nonsusceptible MRSA strain C37. Abbreviations: CFU, colony-forming units; GC, growth control; DAP, daptomycin; CPT, ceftaroline.

Article Snippet: The DNS MRSA strains selected for evaluation in the studies herein were initially isolated from bacteremic patients and obtained from the Cubist Pharmaceuticals Isolate Collection ( 30 ).

Techniques: Ex Vivo, Control

Antibiotic MIC for daptomycin-nonsusceptible MRSA isolates C4 and C37 at baseline and in 168-h SEV samples a

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model

doi: 10.1128/aac.01388-23

Figure Lengend Snippet: Antibiotic MIC for daptomycin-nonsusceptible MRSA isolates C4 and C37 at baseline and in 168-h SEV samples a

Article Snippet: The DNS MRSA strains selected for evaluation in the studies herein were initially isolated from bacteremic patients and obtained from the Cubist Pharmaceuticals Isolate Collection ( 30 ).

Techniques: Control

Frequency of apparent resistance in daptomycin-nonsusceptible MRSA strains C4 and C37 sensitive to each phage a , b , c

Journal: Antimicrobial Agents and Chemotherapy

Article Title: Phage-antibiotic synergy against daptomycin-nonsusceptible MRSA in an ex vivo simulated endocardial pharmacokinetic/pharmacodynamic model

doi: 10.1128/aac.01388-23

Figure Lengend Snippet: Frequency of apparent resistance in daptomycin-nonsusceptible MRSA strains C4 and C37 sensitive to each phage a , b , c

Article Snippet: The DNS MRSA strains selected for evaluation in the studies herein were initially isolated from bacteremic patients and obtained from the Cubist Pharmaceuticals Isolate Collection ( 30 ).

Techniques: